Table 1 Characteristics of patients with travel-related (TRB) and domestically acquired (DAB) bacteremia
Characteristics | TRB (n = 76) | DAB (n = 235) | ||
|---|---|---|---|---|
Age | ||||
Median (years, range) | 36 | (0-79) | 64 | (0-96) |
<65 years (numbers, percent) | 64 | (84.2) | 123 | (52.3) |
≥65 years | 12 | (15.8) | 112 | (47.7) |
Sex | ||||
Males | 49 | (64.5) | 118 | (50.2) |
Admitted to an infectious diseases unita | 29/64 | (45.3) | 8/163 | (4.9) |
Comorbidity indexb | ||||
0 | 54 | (71.1) | 69 | (29.4) |
1-2 | 11 | (14.5) | 91 | (38.7) |
≥3 | 11 | (14.5) | 75 | (31.9) |
Individuals with malignancy | ||||
Hematological malignanciesc | 3 | (3.9) | 23 | (9.8) |
Other malignancies | 6 | (7.9) | 36 | (15.3) |
Other comorbidities | ||||
Dialysisd | 0 | (0.0) | 3 | (1.3) |
Organ transplantation | 0 | (0.0) | 2 | (0.9) |
Alcoholisme | 3 | (3.9) | 21 | (8.9) |
Previous gastric surgeryf | 3 | (3.9) | 5 | (2.1) |
Drug therapy | ||||
Chemotherapy & immunomodulatory agents | 5 | (6.6) | 33 | (14.0) |
Corticosteroid therapy | 2 | (2.6) | 30 | (12.8) |
PPI & H2-antagonist | 7 | (9.2) | 66 | (28.1) |
Antacids | 0 | (0.0) | 8 | (3.4) |
Length of hospital stay (median, IQR) | 8 days | (5-11) | 11 days | (6-17) |
An extraintestinal site of infection | 5 | (6.6) | 31 | (13.2) |
Mortality by age group | ||||
<65 years | ||||
30-day | 3 | (4.7) | 11 | (8.9) |
90-day | 4 | (6.3) | 12 | (9.8) |
≥65 years | ||||
30-day | 0 | (0.0) | 30 | (26.8) |
90-day | 1 | (8.3) | 40 | (35.7) |
Overall | ||||
30-day | 3 | (3.9) | 41 | (17.4) |
90-day | 5 | (6.6) | 52 | (22.1) |